Since our inception, we were catering to the demand of domestic market as well as doing export. On the one hand, we were doing domestic market directly but all our export was done through merchant exporters only. In May 2015, Medipol received WHO  GMP certifications, which allowed the company to go global and start making direct exports. We extended our services beyond the Indian border to Asian and African countries. At the moment, Medipol works directly with Cambodia, Afghanistan, Yemen, Kenya, and several South African countries. Negotiation is ongoing with various other importers and in near future, we will be commencing export in many more countries.

Our goal is to expand further to provide medication on the global level to the patients, who need them the most. We have a team working on compliance with requirements and regulations of other nations to make our products available to them.

Medipol is fully ready to establish the distribution process in as many centers as we can negotiate with outside India. Thanks to our growing medication portfolio and the hard work of our production department, Medipol is on its way to becoming one of the biggest players on the global pharmaceutical market.

The export procedure is different for each country. Knowing this, we are ready to comply with even the toughest requirements on the way to achieving our most desired goal of supplying all the people in need with the highest-quality pharmaceutical products. A dedicated team is engaged in compliance with regulatory affairs and other requirements preparation of dossier according to the specific requirement of importing countries.